Global Carbapenem-Based Antibiotics Market Forecast Report to 2028: Rising Prevalence of Gram-Negative Bacterial Infections and Increasing Production of Generic Drugs – ResearchAndMarkets.com

Global Carbapenem-Based Antibiotics Market Forecast Report to 2028: Rising Prevalence of Gram-Negative Bacterial Infections and Increasing Production of Generic Drugs – ResearchAndMarkets.com




Global Carbapenem-Based Antibiotics Market Forecast Report to 2028: Rising Prevalence of Gram-Negative Bacterial Infections and Increasing Production of Generic Drugs – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Carbapenem-Based Antibiotics Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type, Indication, and Distribution Channel” report has been added to ResearchAndMarkets.com’s offering.

The carbapenem-based antibiotics market size is projected to reach US$ 5,346.62 million by 2028 from US$ 3,964.57 million in 2021; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.

Generic versions of antibiotics are popular due to their availability and affordability. In addition, the expiry of patented carbapenem-based antibiotics has widen-up opportunities for generic drug manufacturers to enter the market with their cost-efficient drugs. The focus of generic drug producers is to increase the reach of these drugs. Moreover, the shortage of antibiotics to treat bacterial infections is also one of the prime factors driving the market’s growth. The increased production of generic carbapenem-based antibiotics has enlarged the drug availability in various low- and middle-income countries.

Based on type, the carbapenem-based antibiotics market is segmented into meropenem, doripenem, imipenem, tebipenem, and others. The others segment held the largest market share of the carbapenem based antibiotics market in 2021, and it is anticipated to register the highest CAGR in the carbapenem-based antibiotics market during the forecast period. The growing developments for carbapenem-based antibiotics are likely to drive the market growth in the future.

Based on indication, the carbapenem-based antibiotics market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections, and others. The others segment held the largest share of the carbapenem-based antibiotics market in 2021 and is estimated to register the highest CAGR in the market during the forecast period.

By distribution channel, the carbapenem-based antibiotics market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment held the largest share of the carbapenem-based antibiotics market in 2021, and it is estimated to register the highest CAGR in the market during the forecast period.

Based on geography, the carbapenem-based antibiotics market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. North America dominates the global market share and is expected to hold its strong foothold in the coming years.

The region is expected to witness a consistent growth in the future owing to factors such as increased adoption of carbapenem based antibiotics, high prescription rate of antibiotics, and advancements in research and development leading to the emergence and launch of new medicines.

However, the market in Asia Pacific is expected to witness the fastest growth in the coming years. The carbapenem-based antibiotics market size in India and China is expected to grow rapidly owing to factors such as the large population, increasing focus of market players on developing novel vaccines and products at affordable prices, and high penetration of market players manufacturing generic drugs and exporting them across the world.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Carbapenem-based Antibiotics Market – By Type

1.3.2 Global Carbapenem-based Antibiotics Market – By Indication

1.3.3 Global Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4 Global Carbapenem-based Antibiotics Market – By Geography

2. Carbapenem-based Antibiotics Market – Key Takeaways

3. Research Methodology

4. Global Carbapenem-based Antibiotics Market – Market Landscape

5. Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1 Drivers

5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2 Increasing Production of Generic Drugs

5.2 Market Restraints

5.2.1 Tedious and Expensive Process of Antibiotic Development

5.3 Market Opportunities

5.3.1 Private and Public Partnerships

5.4 Future Trends

5.4.1 Strategic Advancement for New Antibiotic Identification

5.5 Impact Analysis

6. Carbapenem-based Antibiotics Market – Global Analysis

6.1 Global Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

6.2 Global Carbapenem-based Antibiotics Market, By Geography – Forecast and Analysis

6.3 Market Positioning of Key Players

7. Carbapenem-based Antibiotics Market Analysis – By Type

8. Carbapenem-based Antibiotics Market – By Indication

9. Carbapenem-based Antibiotics Market – By Distribution Channel

10. Carbapenem-based Antibiotics Market – Regional Analysis

11. Impact of COVID-19 Pandemic on Global Carbapenem-based Antibiotics Market

12. Carbapenem-based Antibiotics Market-Industry Landscape

COMPANY PROFILES

  • Pfizer Inc.
  • Savior Lifetec
  • Sumitomo Dainippon Pharma
  • Merck & Co., Inc.
  • Gland Pharma Limited
  • Aurobindo Pharma Ltd
  • Daewoong Pharmaceutical
  • Iterum Therapeutics plc
  • ACS Dobfar S.p.A
  • Spero Therapeutics

For more information about this report visit https://www.researchandmarkets.com/r/i4v7vt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900